Home » Court Rejects Abbott's Request to Dismiss Antitrust Charge Over TriCor
Court Rejects Abbott's Request to Dismiss Antitrust Charge Over TriCor
August 2, 2006
A lawsuit charging that Abbott Laboratories tried to block generic competition to its cholesterol drug TriCor can go forward, a federal court has ruled. The decision provides a “roadmap” for how courts handle some antitrust lawsuits involving drugmakers, according to one antitrust lawyer.